RATIONALE: Food protein induced enterocolitis (FPIES) is a non-IgE mediated food allergy diagnosed in infants and toddlers presenting with severe vomiting and diarrhea leading to shock in 15% of cases. Consulting allergists should keep very-early onset inflammatory bowel disease (VEO-IBD), defined as IBD diagnosed in children 6 years of age or younger in the differential. IBD in this young age group tends to be more severe and is associated with immune dysregulation. METHODS: We present a case of VEO-IBD followed by database review of all patients with VEO-IBD at a large referral center. RESULTS: Our patient is a two-month-old, full term, breastfed female, with a two-week history of lethargy and poor feeding followed by projectile vomiting and profuse watery diarrhea. She was ill-appearing, hypotensive, and admitted to intensive care unit. She was treated with fluid resuscitation and antibiotics. Extensive evaluation was negative for infectious, anatomic and oncologic processes. Trial of elemental formula due to FPIES concerns led to resolution of vomiting but frequent, watery stools persisted. EGD and flexible sigmoidoscopy revealed apoptosis, active and chronic inflammation consistent with VEO-IBD. Immune evaluation was normal. Four hundred fifty patients in our institution were diagnosed with VEO-IBD. Of the entire cohort, 30% had prior a diagnosis of FPIES whereas those diagnosed under two, 69% had prior diagnosis of FPIES. CONCLUSIONS: This case and our experience have demonstrated that VEO-IBD is often initially diagnosed as FPIES. The presentation of persistent diarrhea, blood in the stool, and vomiting in infants or toddlers should prompt the evaluation for VEO-IBD. University of Rochester Medical Center, Golisano Children's Hospital, Rochester, NY. RATIONALE: Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE mediated food allergy characterized by delayed onset severe vomiting and lethargy. Despite the increasing clinical awareness of FPIES, the condition continues to be under diagnosed and there is limited epidemiological data available. This study aimed to improve our knowledge of FPIES by further characterizing the patient population. METHODS: Data was obtained through a retrospective chart review of patients with the diagnosis of FPIES at two main local hospital systems in Rochester, NY. Charts were reviewed for patient demographics, feeding history, symptoms, allergy testing, atopic history, and family history. RESULTS: In total, 44 charts were reviewed. The majority of patients had symptoms to oat (52%), rice (29%), cow's milk (21%), and soy (11%). All patients developed symptoms within 1.5 -3 hours. The average length to diagnosis was 8.43 months from symptom onset and 70% patients had 3 or less episodes prior to diagnosis. Co-morbid atopic conditions and/or a family history of atopy were present in 75% of patients. CONCLUSIONS: By furthering characterizing FPIES, we can better understand the disease process and improve our care of patients with the condition. This study demonstrates the significant lag in diagnosis from symptom onset. Physicians should be aware of FPIES and raise the suspicion of the disorder in the appropriate clinical scenario, especially in patients with other allergic conditions, as our study showed the majority of patients had other allergic disorders. We hope to expand our data by including other hospitals in the near future. (CMP), and is a leading cause of anaphylaxis in children. Oral immunotherapy (OIT) has been shown to induce tolerance in children with CMA and alters the CMPspecific serum immunoglobulin (Ig) E and IgG4 levels. However, the dynamics of CMP-specific serum IgE and IgG4 over the course of milk OIT have not been determined. METHODS: Forty-two children with confirmed CMA by history, skin prick test, and oral food challenge were studied during a controlled trial of OIT to CMA at the Montreal Children's Hospital. Serum was collected at specific time points during the escalation phase which ended at 200 ml of CM and then followed for 12 months while consuming dairy. We used ELISA to measure the serum IgE and IgG4 specific for CMPs: alactalbumin (ALA), b-lactoglobulin (BLG), and casein. RESULTS: CMP-specific serum IgE peaked before the 25ml dose then decreased throughout the remaining escalation phase and maintenance phase while CMP-specific serum IgG4 gradually increased. CMP-specific IgE was predominantly ALA and casein-specific, whereas CMP-specific IgG4 was predominantly BLG and casein-specific. CONCLUSIONS: Successful cow's milk OIT induces significant changes in the levels of CMP-specific serum IgE and IgG4. Both serum IgE and IgG4 has high specificity for casein. In addition, serum IgE has higher specificity for ALA over BLG, while serum IgG4 has higher specificity for BLG over ALA. The results suggest a differential effect in antibody formation which may preclude complete tolerance against ALA following OIT.
University of Rochester Medical Center, Golisano Children's Hospital, Rochester, NY. RATIONALE: Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE mediated food allergy characterized by delayed onset severe vomiting and lethargy. Despite the increasing clinical awareness of FPIES, the condition continues to be under diagnosed and there is limited epidemiological data available. This study aimed to improve our knowledge of FPIES by further characterizing the patient population. METHODS: Data was obtained through a retrospective chart review of patients with the diagnosis of FPIES at two main local hospital systems in Rochester, NY. Charts were reviewed for patient demographics, feeding history, symptoms, allergy testing, atopic history, and family history. RESULTS: In total, 44 charts were reviewed. The majority of patients had symptoms to oat (52%), rice (29%), cow's milk (21%), and soy (11%). All patients developed symptoms within 1.5 -3 hours. The average length to diagnosis was 8.43 months from symptom onset and 70% patients had 3 or less episodes prior to diagnosis. Co-morbid atopic conditions and/or a family history of atopy were present in 75% of patients. CONCLUSIONS: By furthering characterizing FPIES, we can better understand the disease process and improve our care of patients with the condition. This study demonstrates the significant lag in diagnosis from symptom onset. Physicians should be aware of FPIES and raise the suspicion of the disorder in the appropriate clinical scenario, especially in patients with other allergic conditions, as our study showed the majority of patients had other allergic disorders. We hope to expand our data by including other hospitals in the near future. (CMA) is characterized by an inappropriate immune response to cow's milk protein (CMP), and is a leading cause of anaphylaxis in children. Oral immunotherapy (OIT) has been shown to induce tolerance in children with CMA and alters the CMPspecific serum immunoglobulin (Ig) E and IgG4 levels. However, the dynamics of CMP-specific serum IgE and IgG4 over the course of milk OIT have not been determined. METHODS: Forty-two children with confirmed CMA by history, skin prick test, and oral food challenge were studied during a controlled trial of OIT to CMA at the Montreal Children's Hospital. Serum was collected at specific time points during the escalation phase which ended at 200 ml of CM and then followed for 12 months while consuming dairy. We used ELISA to measure the serum IgE and IgG4 specific for CMPs: alactalbumin (ALA), b-lactoglobulin (BLG), and casein. RESULTS: CMP-specific serum IgE peaked before the 25ml dose then decreased throughout the remaining escalation phase and maintenance phase while CMP-specific serum IgG4 gradually increased. CMP-specific IgE was predominantly ALA and casein-specific, whereas CMP-specific IgG4 was predominantly BLG and casein-specific. CONCLUSIONS: Successful cow's milk OIT induces significant changes in the levels of CMP-specific serum IgE and IgG4. Both serum IgE and IgG4 has high specificity for casein. In addition, serum IgE has higher specificity for ALA over BLG, while serum IgG4 has higher specificity for BLG over ALA. The results suggest a differential effect in antibody formation which may preclude complete tolerance against ALA following OIT.
